SEC SCHEDULE 13G

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

September 9, 2022

Accession Number

0001422849-22-000166

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →